(Total Views: 430)
Posted On: 05/18/2021 12:02:53 PM
Post# of 148892
"We need to do something big and bold now!...We need to do something now while we still can."
Well yes, that sounds amazing and I am with you, however what do you suggest? Such language without ideas leaves one angry, frustrated, and still sitting on the couch.
Truth is, based on CYDY's own design of the trial, it failed to meet its primary endpoints. Forget that we hit our secondary endpoints and that we were not allowed to change protocol to 4 injections which we now know would have most likely gotten us to the primary endpoints. CYDY did not hit its mark by its own design and the FDA is "simply following orders" and clearly not thinking outside the box here in the slightest.
I agree with you that if this spooks our foreign ties in connection with covid, it's game over unless/until the Brazil trials show something meaningful. And yes, sadly, I agree with you that it is pretty damn clear right now that the FDA is not going to treat CYDY fairly when it comes to HIV, NASH, Cancer, or anything else. Does that mean we give up and sell? Well, I for one don't think so. Then again, I am not doubling down right now either, despite the share price as I write this ($1.93). Hell...I hope not buying more right now looks like a crap decision in hindsight in the not too distant future!
Well yes, that sounds amazing and I am with you, however what do you suggest? Such language without ideas leaves one angry, frustrated, and still sitting on the couch.
Truth is, based on CYDY's own design of the trial, it failed to meet its primary endpoints. Forget that we hit our secondary endpoints and that we were not allowed to change protocol to 4 injections which we now know would have most likely gotten us to the primary endpoints. CYDY did not hit its mark by its own design and the FDA is "simply following orders" and clearly not thinking outside the box here in the slightest.
I agree with you that if this spooks our foreign ties in connection with covid, it's game over unless/until the Brazil trials show something meaningful. And yes, sadly, I agree with you that it is pretty damn clear right now that the FDA is not going to treat CYDY fairly when it comes to HIV, NASH, Cancer, or anything else. Does that mean we give up and sell? Well, I for one don't think so. Then again, I am not doubling down right now either, despite the share price as I write this ($1.93). Hell...I hope not buying more right now looks like a crap decision in hindsight in the not too distant future!
(4)
(0)Scroll down for more posts ▼
